Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews · Haematology

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 100%Moderate 0 · 0%High 0 · 0%

Overall survival (number of deaths at · Patients with treating MF

Ruxolitinib may leads to lower overall survival (number of deaths at compared with placebo (low certainty).

1 finding from 1 review

Janus kinase‐1 and Janus kinase‐2 inhibitors for treating myelofibrosis 2015 · Cochrane Headline outcomes only
HR 0.51 [0.27, 0.98]
1 study · 309 participants
Low